Data / New clinical trials / Precursor Cell Lymphoblastic Leukemia-Lymphoma

Precursor Cell Lymphoblastic Leukemia-Lymphoma: 188 new

Name: New Precursor Cell Lymphoblastic Leukemia-Lymphoma clinical trials
Creator: SpecStream
License: https://creativecommons.org/licenses/by/4.0/

The full list. New Precursor Cell Lymphoblastic Leukemia-Lymphoma clinical trials: 188 rows for $9.40, first posted on ClinicalTrials.gov from November 12, 2024 to November 9, 2026. The list gains about 6 rows a month. The new rows come each week by email, $19 a month.

Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (central contact, contact phone, contact email, sponsor class, condition groups (MeSH), interventions and 5 more), which open on your screen as soon as the payment clears and come by email. The weekly rows run until you cancel, from the link in each delivery. The rows on this page are a sample.

For agents and scripts: this list is ordered at https://specstream.ai/data/clinical-trials/condition/precursor-cell-lymphoblastic-leukemia-lymphoma, and every list with its row count and price is at https://specstream.ai/data/lists.json.

Updated November 6, 2026. Source: ClinicalTrials.gov API v2 (U.S. National Library of Medicine).

188 clinical studies in Precursor Cell Lymphoblastic Leukemia-Lymphoma were first posted on ClinicalTrials.gov from November 26, 2024 to November 6, 2026; 22 have an industry sponsor and 158 are recruiting or about to. The newest, NCT07923071, was posted on November 6, 2026: A Study to Assess the Pharmacokinetics and Safety of Revumenib in Participants With Advanced Cancer and... (Syndax Pharmaceuticals).

The request: Every new Precursor Cell Lymphoblastic Leukemia-Lymphoma clinical trial on ClinicalTrials.gov, with the sponsor, phase, sites and the listed contact. $10 of credit on sign-up, no card.

Get new trials like these Watch a sponsor

SpecStream is the live web data engine for teams and agents. It reads every new study on ClinicalTrials.gov each morning, and this page is that reading. Ask for the conditions, phases or countries you follow and each new trial arrives in your sheet, CRM, Slack or agent with the sponsor, the sites and the listed contact.

188New trials
22Industry sponsored
158Recruiting or not yet
November 6, 2026Latest posted

Newest trials

The newest 100 of 188, each linked to its record. The full list holds every one with the sponsor class, interventions, start date and the central contact as the record prints it.

First posted	NCT ID	Title	Sponsor	Phase	Status	Conditions	Enrollment	Countries	Source
November 6, 2026	NCT07923071	A Study to Assess the Pharmacokinetics and Safety of Revumenib in Participants With Advanced Cancer and Hepatic or Renal Impairment	Syndax Pharmaceuticals	Phase 1	Not yet recruiting	Relapsed/Refractory (R/R) Hematologic Malignancies, Acute Leukemia, Refractory Leukemia, Relapsed Leukemia	18		clinicaltrials.gov
November 5, 2026	NCT07919470	Busulfan-Based Versus TBI-Based Conditioning for Adult ALL-CR2 Allo-HSCT	Peking University People's Hospital	Not applicable	Not yet recruiting	Acute Lymphoblastic Leukemia, Hematopoietic Stem Cell Transplantation	180	China	clinicaltrials.gov
October 23, 2026	NCT07891468	huCART19-IL18-CD428z Cells for the Treatment of Patients With HIV With CD19+ Cancers	University of Pennsylvania	Phase 1	Not yet recruiting	Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Acute Lymphoblastic Leukemia, Richter's Transformation	6	United States	clinicaltrials.gov
October 22, 2026	NCT07890025	CD19 CAR-T Cell Therapy in Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: A Phase I/II Study	Hospital Universitario Dr. Jose E. Gonzalez	Phase 1/2	Not yet recruiting	Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia	30	Mexico	clinicaltrials.gov
October 20, 2026	NCT07884474	Feasibility and Acceptability of Remote Saliva Collection	St. Jude Children's Research Hospital	Observational	Recruiting	Survivors of Childhood Cancer, Acute Lymphoblastic Leukemia, Childhood	100	United States	clinicaltrials.gov
October 20, 2026	NCT07883941	Phase I Safety Clinical Trial of Anti-CD19 CAR-T Therapy COL01 for the Treatment of Adults With Relapsed or Refractory B-cell Lymphoid...	GUSTAVO SALGUERO	Phase 1	Not yet recruiting	Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia, Lymphoid Malignancies, Diffuse Large B Cell Lymphoma...	12		clinicaltrials.gov
October 20, 2026	NCT07882069	Effect of ACTIVE-Care on Cancer-Related Fatigue, Hope, and Psychological Resilience in Adolescents With Acute Lymphoblastic Leukemia	Selcuk University	Not applicable	Completed	Cancer (Colon Cancer, Breast Cancer, Lymphoma, Chronic Lymphoma Leukemia, Multiple Myeloma), Adolescent, Resilience...	70	Turkey (Türkiye)	clinicaltrials.gov
October 5, 2026	NCT07858214	Measurement of Ocular Microtremor With the iTremor Device in a Diverse US Cohort	Head Diagnostics	Observational	Enrolling by invitation	All Conditions, All	120	United States	clinicaltrials.gov
October 5, 2026	NCT07856758	2 Gy Total Body Irradiation As Part Of Conditioning Treatment For Patients With Acute Lymphoblastic Leukemia Undergoing CAR T Cell Therapy	M.D. Anderson Cancer Center	Not applicable	Not yet recruiting	Acute Lymphoblastic Leukemia	20	United States	clinicaltrials.gov
September 14, 2026	NCT07819396	Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic...	Fred Hutchinson Cancer Center	Phase 2	Not yet recruiting	Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute...	52	United States	clinicaltrials.gov
September 10, 2026	NCT07814170	A Manualised Post-Traumatic Growth Intervention For People With Hematological Cancers In Greece	University of West Attica	Not applicable	Active not recruiting	Blood Cancers, Leukemia, Lymphoma, Bone Marrow Transplant, Psychological Trauma, Neoplasms, Hematological Malignancies...	80	Greece	clinicaltrials.gov
September 10, 2026	NCT07813208	Ph+ ALL in Chinese Children: Diagnosis, Treatment, and Survival	The Children's Hospital of Zhejiang University School of Medicine	Observational	Recruiting	Acute Lymphoblastic Leukemia, Pediatric	500	China	clinicaltrials.gov
September 9, 2026	NCT07809984	Prevention of Oral Mucositis in Adults in With Hematologic Malignancy	Wake Forest University Health Sciences	Not applicable	Not yet recruiting	Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Oral Mucositis	206	United States	clinicaltrials.gov
August 31, 2026	NCT07795099	A Single-center, Prospective, Exploratory Clinical Study	LanZhou University	Not applicable	Not yet recruiting	Acute Lymphoblastic Leukemia	30		clinicaltrials.gov
August 25, 2026	NCT07784309	A Clinical Study of HY035 Cell Injection in the Treatment of CD7-positive Relapsed or Refractory Hematologic Malignancies	Institute of Hematology & Blood Diseases Hospital, China	Phase 1	Enrolling by invitation	Acute T Cell Lymphoblastic Leukemia, Lymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Refractory...	13	China	clinicaltrials.gov
August 21, 2026	NCT07780123	Nurture by Nature Feasibility Study	Ina Olmer Specht	Not applicable	Recruiting	Nature, Human, Pediatric ALL, Well-Being, Psychological	127	Denmark	clinicaltrials.gov
August 18, 2026	NCT07770698	A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia	BeOne Medicines	Phase 1/2	Not yet recruiting	Relapsed Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, B-cell Acute Lymphoblastic Leukemia, Pediatric...	30		clinicaltrials.gov
August 13, 2026	NCT07763054	Low-dose Liposomal Amphotericin B for Antifungal Prophylaxis in Prolonged Neutropenia Patients	Haikou Affiliated Hospital of Central South University Xiangya School of Medicine	Observational	Recruiting	Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Lymphoma, Multiple Myeloma, Chronic...	30	China	clinicaltrials.gov
August 7, 2026	NCT07751588	Plasma ctDNA Monitoring in Pediatric Acute Leukemia	Institute of Hematology & Blood Diseases Hospital, China	Observational	Not yet recruiting	Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia	25	China	clinicaltrials.gov
August 3, 2026	NCT07742891	ReSeT in ALL 2: A Randomized, Controlled Pilot Trial Testing an Optimized, Multi-component Mobile Health Intervention to Reduce Sedentary...	Children's Hospital Los Angeles	Not applicable	Not yet recruiting	Acute Lymphoblastic Leukemia (ALL), Sedentary Behavior / Physical Inactivity, Cardiometabolic Health	50		clinicaltrials.gov
July 17, 2026	NCT07710781	Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic...	Ossium Health, Inc.	Not applicable	Not yet recruiting	Hematologic Malignancy, Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Biphenotypic...	300		clinicaltrials.gov
July 15, 2026	NCT07705178	More Than Just X-Rays - Imaging of Chemotherapy-induced Morphological and Functional Cardiovascular and Lung Changes After Childhood ALL...	University of Erlangen-Nürnberg Medical School	Not applicable	Recruiting	Acute Lymphatic Leukemia, Lymphoma	180	Germany	clinicaltrials.gov
July 10, 2026	NCT07696481	Clinical Study on the Safety and Efficacy of PID23 Injection in Patients With Relapsed/Refractory Acute Leukemia	Zhujiang Hospital	Early phase 1	Not yet recruiting	Relapsed or Refractory Acute Leukemia, Relapsed or Refractory Acute Lymphoblastic Leukemia, Relapsed or Refractory...	18	China	clinicaltrials.gov
July 10, 2026	NCT07695012	CAR-T Cell Therapy for ALL	Dr. Zaineb Akram	Early phase 1	Recruiting	Relapsed Acute Lymphoblastic Leukemia (ALL)	10	Pakistan	clinicaltrials.gov
July 6, 2026	NCT07684131	EWALL-PH OBSERVARTORY 2022	Versailles Hospital	Observational	Recruiting	Acute Lymphoblastic Leukemia	100	France	clinicaltrials.gov
June 12, 2026	NCT07644351	A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lymphoblastic Leukemia Patients	Novartis Pharmaceuticals	Observational	Completed	Acute Lymphoblastic Leukemia	37	Australia, Canada, China, France, Israel, Italy, Netherlands, Pakistan, Poland...	clinicaltrials.gov
June 9, 2026	NCT07634653	Strength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)	UNC Lineberger Comprehensive Cancer Center	Not applicable	Recruiting	Leukemia, Acute Leukemia, Acute Lymphoid Leukemia, Lymphoblastic Lymphoma, Acute Lymphoblastic Leukemia	40	United States	clinicaltrials.gov
June 8, 2026	NCT07632014	CAYA Cancer Prospective Cohort Study	Resonance, Inc.	Observational	Recruiting	Cancer, Pediatric Cancer, Lymphoblastic Lymphoma (LBL), Acute Lymphoblastic Leukemia (ALL)	6,000	Armenia, Egypt, El Salvador, Guatemala, Honduras	clinicaltrials.gov
June 3, 2026	NCT07623655	CAR-T Treatment in Pediatric and Adult Acute Lymphoblastic Leukemia	Gruppo Italiano Malattie EMatologiche dell'Adulto	Observational	Not yet recruiting	Acute Lymphoblastic Leukemia, B-Cell Acute Lymphoblastic Leukaemia	107		clinicaltrials.gov
May 29, 2026	NCT07616089	Phase I Study of FXS0683 in the Treatment of Blood Tumors	Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd.	Phase 1	Recruiting	B-Cell Lymphoma, Acute Myeloid Leukemia, Myelodysplastic Syndromes, Acute Lymphoblastic Leukemia	228	China	clinicaltrials.gov
May 29, 2026	NCT07614022	A Study of LP-118 In Combination With Ponatinib, Dexamethasone And Blinatumomab For Adults With Newly-Diagnosed, BCR::ABL1-Positive Acute...	Wake Forest University Health Sciences	Phase 1	Recruiting	Philadelphia Positive Acute Lymphoblastic Leukemia	26	United States	clinicaltrials.gov
May 19, 2026	NCT07597590	Digital Patient-Reported Assessment in Older Adults With Acute Leukemia	Fundación para la Investigación Biosanitaria del Principado de Asturias	Not applicable	Not yet recruiting	Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia	20	Spain	clinicaltrials.gov
May 14, 2026	NCT07586618	First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic...	Allterum Therapeutics, Inc	Phase 1	Recruiting	Lymphoblastic Lymphoma, Acute Lymphoblastic Leukemia ALL	24	United States	clinicaltrials.gov
May 13, 2026	NCT07584889	Efficacy and Safety of CD19-CAR.p40-T in Patients With Relapsed/Refractory CD19-Positive Hematologic Malignancies	Shenzhen University General Hospital	Phase 1/2	Recruiting	B Cell Lymphoma, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia	10	China	clinicaltrials.gov
May 11, 2026	NCT07577531	Autologous Versus Allogeneic Hematopoietic Stem Cell Transplantation for T-Lymphoblastic Leukemia/Lymphoma in First Complete Remission	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	Observational	Not yet recruiting	T Cell Acute Lymphoblastic Leukemia/Lymphoblastic Lymphoma	84		clinicaltrials.gov
May 8, 2026	NCT07575412	SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS	The First Affiliated Hospital of Soochow University	Phase 2	Not yet recruiting	Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS, Transplantation, Stem Cell, Conditioning Therapy, SHR2554...	180	China	clinicaltrials.gov
May 7, 2026	NCT07573111	Study of QUAIL-100 in Pediatric and Young Adult Participants With High-Risk Hematologic Malignancies Who Have Received a Hematopoietic Stem...	Laguna Biotherapeutics, Inc.	Phase 1	Recruiting	Acute Leukemia, Myelodysplastic Syndrome	12	United States	clinicaltrials.gov
May 7, 2026	NCT07572136	Anti-CRLF2-R/TSLPR Chimeric Antigen Receptor T Cells (TSLPR-CART) in Participants With Recurrent or Refractory CRLF2-R/TSLPR-Overexpressing...	National Cancer Institute (NCI)	Phase 1	Recruiting	B-All, Acute Lymphoblastic Leukemia	57	United States	clinicaltrials.gov
May 5, 2026	NCT07566377	Cord Blood Transplantation in Children and Young Adults With Blood Cancer	Memorial Sloan Kettering Cancer Center	Phase 2	Recruiting	Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Non-hodgkin Lymphoma, Hodgkin...	71	United States	clinicaltrials.gov
May 4, 2026	NCT07565220	Thiotepa-based Conditioning Regimen With De-escalated Post-graft Cyclophosphamide for Allogeneic Stem Cell Transplantation in Hematologic...	Sawa Ito, MD	Phase 1	Recruiting	Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), Acute Leukemia, Myelodysplastic Syndrome(MDS)...	48	United States	clinicaltrials.gov
May 1, 2026	NCT07562568	SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS	The First Affiliated Hospital of Soochow University	Phase 2	Not yet recruiting	Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, MDS, Transplantation, Stem Cell, Conditioning Therapy, SHR2554...	160	China	clinicaltrials.gov
April 14, 2026	NCT07529223	Role of T Lymphocytes in Hypersensitivity Reactions to Asparaginase in Patients Treated for Acute Lymphoblastic Leukemia.	Centre Hospitalier Universitaire de Nice	Not applicable	Not yet recruiting	Acute Lymphoblastic Leukemia ALL	20	France	clinicaltrials.gov
April 13, 2026	NCT07522905	Virtual Buddy Movement Therapy for Psychomotor and Social Development in Pediatric Oncology Patients in Remission	Comenius University	Not applicable	Recruiting	Precursor Cell Lymphoblastic Leukemia-Lymphoma	24	Slovakia	clinicaltrials.gov
April 8, 2026	NCT07518654	Phase I Clinical Trial of ThINKK Adoptive Immunotherapy After Allogeneic Hematopoietic Transplantation in Children With Leukemia or...	Michel Duval	Phase 1	Not yet recruiting	Leukaemia (Acute Lymphoblastic), Leukaemia (Acute Myeloid), Neuroblastoma, Neuroblastoma, Metastatic, Leukaemia...	12	Canada	clinicaltrials.gov
April 8, 2026	NCT07516353	my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults	Dana-Farber Cancer Institute	Not applicable	Not yet recruiting	Sarcoma, Osteosarcoma, Ewing Sarcoma, Rhabdomyosarcoma, Acute Myeloid Leukemia, Aml, ALL, Medulloblastoma, Acute...	143	United States	clinicaltrials.gov
April 7, 2026	NCT07515430	The Association Between Gut Microbiome Composition Signature and Cancer-related Symptoms in Children With Acute Lymphoblastic Leukemia	Sun Yat-sen University	Observational	Enrolling by invitation	Acute Lymphoblastic Leukemia	138	China	clinicaltrials.gov
April 3, 2026	NCT07509385	The Role of Serum Cytokines IL_17 A and IL_10 in Disease Activity of Acute B Lymphoblastic Leukemia in South Egypt	Assiut University	Observational	Not yet recruiting	Acute Lymphoblastic Leukemia, B-Cell	80		clinicaltrials.gov
March 30, 2026	NCT07499349	Establishment of a Phamacokinetik Model for Erwinase Pharmacokinetiks: The Aim of This Sub Study is to Optimize Target Trough Attainment...	Aarhus University Hospital	Observational	Recruiting	Acute Lymphoblastic Leukemia	475	Denmark	clinicaltrials.gov
March 30, 2026	NCT07499128	Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event	National Cancer Institute (NCI)	Not applicable	Enrolling by invitation	Cytokine Release Syndrome, Neoplasms, Lymphoma, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Multiple Myeloma...	136	United States	clinicaltrials.gov
March 27, 2026	NCT07498465	A Study to Find the Highest Dose of SNDX-5613 (Revumenib) as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With...	Children's Oncology Group	Phase 1	Withdrawn	Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid...	0		clinicaltrials.gov
March 27, 2026	NCT07495631	Pediatric-Inspired Regimen Combined With Venetoclax and Immunotherapy for Adult Ph-Negative Acute Lymphoblastic Leukemia	Institute of Hematology & Blood Diseases Hospital, China	Not applicable	Recruiting	Acute Lymphoblastic Leukemia, Adult	43	China	clinicaltrials.gov
March 19, 2026	NCT07483749	HEM-SURVIVE: Structuralized Follow-up for Childhood Hematological Malignancy Survivors	The Children's Hospital of Zhejiang University School of Medicine	Observational	Not yet recruiting	Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Lymphoma, Leukemia, Pediatric	400	China	clinicaltrials.gov
March 19, 2026	NCT07483476	Study of Cell-free DNA in Children and Adolescents With Acute Lymphoblastic Leukemia	Assistance Publique - Hôpitaux de Paris	Observational	Recruiting	Acute Lymphoblastic Leukemia ALL	205	France	clinicaltrials.gov
March 18, 2026	NCT07479927	Telematic Cognitive Training and Mindfulness in Pediatric Patients After CAR-T Cell Therapy, Single Hematopoietic Allogeneic Transplant or...	Hospital Universitario La Paz	Not applicable	Recruiting	Acute Lymphoblastic Leukemia	40	Spain	clinicaltrials.gov
March 13, 2026	NCT07469592	eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation	University of Miami	Not applicable	Recruiting	Stem Cell Transplantation, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic...	165	United States	clinicaltrials.gov
March 10, 2026	NCT07462299	NUDT15/TPMT Multi-gene Guided 6-MP Dosing in Childhood ALL Maintenance Therapy	The Children's Hospital of Zhejiang University School of Medicine	Not applicable	Not yet recruiting	Childhood Acute Lymphoblastic Leukemia	110	China	clinicaltrials.gov
March 6, 2026	NCT07454226	ABL/JAK Inhibitors With Chemotherapy and Venetoclax for Ph-like ALL	Institute of Hematology & Blood Diseases Hospital, China	Not applicable	Recruiting	Ph-Like, Acute Lymphoblastic Leukemia	92	China	clinicaltrials.gov
March 5, 2026	NCT07451743	Are Clinical Outcomes Unchanged by ALL Fixation at 0° or 30° of Knee Flexion in Combined ACL-ALL Reconstruction? Despite Numerous Technical...	ASL Lecce	Not applicable	Not yet recruiting	Anterior Cruciate Ligament Rupture	100		clinicaltrials.gov
March 2, 2026	NCT07443592	Treatment for Ph-negative ALL for Adults up to 65 Years	PETHEMA Foundation	Not applicable	Not yet recruiting	Acute Lymphoblastic Leukemia	330	Spain	clinicaltrials.gov
February 23, 2026	NCT07428486	A Phase 1 Study Of FLAG Chemotherapy In Combination With Lisaftoclax And Pelcitoclax In Patients With Relapsed/Refractory T-Cell Acute...	M.D. Anderson Cancer Center	Phase 1	Withdrawn	Phase I, FLAG Chemotherapy, Lisaftoclax, Pelcitoclax, Relapsed/Refractory, Lymphoblastic Leukemia Acute	0		clinicaltrials.gov
February 11, 2026	NCT07403630	INTEGRATIVE "MULTI-OMICS" AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC...	Azienda Ospedaliero-Universitaria di Parma	Not applicable	Recruiting	Acute Leukemia, Multiple Myeloma, Squamous Cell Carcinoma, Pleural Mesothelioma, Pancreatic Cancer, Bladder Cancer...	300	Italy	clinicaltrials.gov
February 10, 2026	NCT07400029	A Study of Obecabtagene Autoleucel in People With B-cell Acute Lymphoblastic Leukemia	Memorial Sloan Kettering Cancer Center	Phase 2	Recruiting	Acute Lymphoblastic Leukemia	40	United States	clinicaltrials.gov
February 4, 2026	NCT07387926	Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class...	Novartis Pharmaceuticals	Phase 1/2	Recruiting	Acute Lymphoblastic Leukemia, Leukemia, Lymphoblastic, Acute, Philadelphia-Positive, Philadelphia Chromosome Positive...	50	Australia, Israel, South Korea, Taiwan	clinicaltrials.gov
January 28, 2026	NCT07374315	Weight Gain in Pediatric Leukemia Survivors	Washington University School of Medicine	Not applicable	Not yet recruiting	Leukemia, Pediatric Acute Lymphoblastic Leukemia, Pediatric Acute Lymphoblastic Leukemia in Remission, Pediatric Obesity	80	United States	clinicaltrials.gov
January 28, 2026	NCT07371533	Clinical Study of Recombinant Anti-CD19m-CD3 Antibody Injection (A-319)	Shanxi Bethune Hospital	Not applicable	Not yet recruiting	Acute Lymphocytic Leukemia	18		clinicaltrials.gov
January 27, 2026	NCT07371403	MB-CART19.1 in Relapsed/Refractory Acute Lymphoblastic Leukemia	King Hussein Cancer Center	Not applicable	Recruiting	Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia Recurrent, Acute Lymphoblastic Leukemia Refractory, Acute...	12	Jordan	clinicaltrials.gov
January 26, 2026	NCT07366801	Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After...	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	Phase 2/3	Recruiting	Acute Myeloid Leukemia, Relapsed, Acute Lymphoblastic Leukemia, High Risk, Acute Myeloid Leukemia, High Risk, Acute...	64	Russia	clinicaltrials.gov
January 22, 2026	NCT07361029	CD19 Chimeric Antigen Receptor (CAR) T Cells in Adults With Relapsed/Refractory CD19 Positive Acute Lymphoblastic Leukemia	King Faisal Specialist Hospital & Research Center	Phase 1	Recruiting	Relapsed Refractory Acute Lymphoblastic Leukemia	24	Saudi Arabia	clinicaltrials.gov
January 21, 2026	NCT07356960	Evaluation of the Efficacy of Ponatinib in Ph+ ALL in the Real-world	Gruppo Italiano Malattie EMatologiche dell'Adulto	Observational	Not yet recruiting	Acute Lymphobkastic Leukemia, Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia	103		clinicaltrials.gov
January 21, 2026	NCT07356154	A Study of Revumenib and Mezigdomide in People With Leukemia	Memorial Sloan Kettering Cancer Center	Phase 1/2	Recruiting	Leukemia, Acute Leukemia, Relapse Leukemia, Refractory Leukemia, Refractory Acute Leukemia, Acute Myeloid Leukemia...	52	United States	clinicaltrials.gov
January 16, 2026	NCT07346105	Orca-T Expanded Access Program Study for Patients With Advanced Hematologic Malignancies	Orca Biosystems, Inc.	Not applicable	Available	Hematologic Malignancies, Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Myelodysplastic Syndrome, Mixed Phenotype...	Not listed	United States	clinicaltrials.gov
January 9, 2026	NCT07328503	CD22 CAR T-cells to Extend Remission Following Commercial CD19 CAR T-cells in Children, Adolescents, and Adults With Relapsed/Refractory...	National Cancer Institute (NCI)	Phase 2	Recruiting	Acute Lymphoblastic Leukemia, B-All	20	United States	clinicaltrials.gov
January 8, 2026	NCT07327138	Children's Laughter and Fun Yoga as Adjunctive Pain Relief Following Chemotherapy.	Bahaa Bou Dargham	Not applicable	Recruiting	Acute Lymphoblastic Leukemia ALL	60	Lebanon	clinicaltrials.gov
January 8, 2026	NCT07326930	Tracjectories and Predictors of Chemotherapy Induced Peripheral Neuropathy in Children With Acute Lymphoblastic Leukemia	The Hong Kong Polytechnic University	Observational	Recruiting	Acute Lymphoblastic Leukemia ALL	173	China	clinicaltrials.gov
January 8, 2026	NCT07325305	Physical Activity and Exercise During Early Treatment Phases for Childhood Acute Lymphoblastic Leukaemia to Protect Against Muscle Loss and...	Murdoch Childrens Research Institute	Not applicable	Recruiting	Sarcopenia, Acute Lymphoblastic Leukemia	60	Australia	clinicaltrials.gov
January 6, 2026	NCT07320534	Levofloxacin Prophylaxis to Prevent First Febrile Neutropenia in Pediatric ALL During Induction Phase	Gadjah Mada University	Phase 4	Terminated	Neutropenic Fever, Acute Lymphoblastic Leukemia	49	Indonesia	clinicaltrials.gov
January 6, 2026	NCT07319481	Preliminary Effectiveness and Feasibility of Transcutaneous Acupoints Electrical Stimulation on Chemotherapy-induced Peripheral Neuropathy...	The Hong Kong Polytechnic University	Not applicable	Not yet recruiting	Chemotherapy Induced Peripheral Neuropathy (CIPN)	60	China	clinicaltrials.gov
January 2, 2026	NCT07313592	Whole Genome Sequencing (ChromoSeq®) for Acute Lymphoblastic Leukemia (ALL) Patients	Washington University School of Medicine	Observational	Recruiting	Acute Lymphoblastic Leukemia	60	United States	clinicaltrials.gov
December 31, 2025	NCT07312630	Clinical Study of LV009 Injection for the Treatment of Relapsed/Refractory CD19-Positive Hematologic and Lymphoid Malignancies	PersonGen BioTherapeutics (Suzhou) Co., Ltd.	Early phase 1	Recruiting	Non-Hodgkin Lymphoma (NHL), Acute Lymphoblastic Leukemia (ALL), Adult	19	China	clinicaltrials.gov
December 24, 2025	NCT07301424	Subcutaneous Blinatumomab Plus Ponatinib for BCR-ABL+ B-ALL	University of Alberta	Phase 2	Not yet recruiting	Acute Lymphoblastic Leukemia (ALL) Philadelphia Chromosome-positive (Ph+), BCR-ABL Positive Acute Lymphoblastic Leukemia	80	Canada	clinicaltrials.gov
December 24, 2025	NCT07301138	BEBT-908 Plus Chemotherapy Treatment for CR MRD-Positive MEF2D-Rearranged and Pre-B Acute Lymphoblastic Leukemia Patients	Ruijin Hospital	Phase 2	Not yet recruiting	Acute Lymphoblastic Leukemia	23	China	clinicaltrials.gov
December 22, 2025	NCT07297914	Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL	Bambino Gesù Hospital and Research Institute	Phase 2/3	Recruiting	Acute Lymphoblastic Leukemia (ALL), Stem Cell Transplant, Graft -Versus-host-disease	1,000	Austria, Czechia, Denmark, Finland, France, Germany, Italy, Norway, Poland	clinicaltrials.gov
December 22, 2025	NCT07295951	A Study of 14C-Bleximenib (Radiolabeled) in Participants With Acute Leukemia	Janssen Research & Development, LLC	Phase 1	Completed	Acute Lymphoblastic Leukemia, Acute Leukemias, Acute Myeloid Leukemia	6	United Kingdom	clinicaltrials.gov
December 16, 2025	NCT07284927	Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies	PersonGen BioTherapeutics (Suzhou) Co., Ltd.	Phase 1	Recruiting	Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia	10	China	clinicaltrials.gov
December 16, 2025	NCT07283640	A Phase IB Trial of Subcutaneous Blinatumomab in Combination With Revumenib for Patients With KMT2A-rearranged Acute Lymphoblastic Leukemia	M.D. Anderson Cancer Center	Phase 1	Not yet recruiting	Blinatumomab, Revumenib, Lymphoblastic Leukemia, KMT2A-rearranged	20	United States	clinicaltrials.gov
December 2, 2025	NCT07258043	Efficacy of Dose-Adjusted Regimen on Survival in Frail Adults With Acute Lymphoblastic Leukemia	Hospital General de Mexico	Observational	Recruiting	Acute Lymphobkastic Leukemia, Leukemia, Overall Survival	45	Mexico	clinicaltrials.gov
December 2, 2025	NCT07257419	CD45RA-depleted CD19-CAR T Cell Consolidation After TCRαβ+/CD19 B Cell-depleted Haploidentical Hematopoietic Cell Transplantation for...	St. Jude Children's Research Hospital	Phase 1	Recruiting	Relapsed Pediatric ALL, Hematopoietic Cell Transplantation, Hematologic Malignancy	70	United States	clinicaltrials.gov
November 28, 2025	NCT07254793	Prophylactic DLI-X for Leukemia Relapse After HCT	University of Arizona	Phase 1	Recruiting	Acute Lymphoid Leukemia, Acute Myeloid Leukemia, Acute Undifferentiated Leukemia (AUL), Myelodysplastic Syndrome...	180	United States	clinicaltrials.gov
November 24, 2025	NCT07246213	CAYA Cancer Retrospective Cohort Study	Resonance, Inc.	Observational	Recruiting	Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma, Young Adult Cancer, Adolescent Cancer, Childhood Cancers, Acute...	18,000	Armenia, Egypt, El Salvador, Guatemala, Honduras, Tanzania	clinicaltrials.gov
November 20, 2025	NCT07238907	A Multi-center Retrospective Study of INO Treating B-ALL	Ruijin Hospital	Observational	Active not recruiting	Acute Lymphoblastic Leukaemia, Acute Lymphoblastic Leukaemias (ALL), Inotuzumab Ozogamicin, Venetoclax	102	China	clinicaltrials.gov
November 14, 2025	NCT07228741	Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity	St. Jude Children's Research Hospital	Phase 2	Recruiting	Acute Lymphoblastic Leukemia, Obesity	20	United States	clinicaltrials.gov
November 12, 2025	NCT07227584	ALL Backbone in AYAs	Dana-Farber Cancer Institute	Phase 2	Recruiting	Acute Lymphoblastic Leukemia, Philadelphia Chromosome-Negative Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia...	67	United States	clinicaltrials.gov
November 4, 2025	NCT07224100	Dose-Adjusted EPOCH With or Without Rituximab Plus Ponatinib for the Treatment of Newly-Diagnosed Philadelphia Chromosome Positive Acute...	University of Washington	Phase 2	Recruiting	B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, B Lymphoblastic Leukemia/Lymphoma With...	33	United States	clinicaltrials.gov
October 31, 2025	NCT07223190	A Study Evaluating Subcutaneous Versus Intravenous Blinatumomab in Newly Diagnosed Adults With B-cell Precursor Acute Lymphoblastic...	Amgen	Phase 3	Not yet recruiting	Philadelphia Chromosome Negative B-cell Precursor Acute Lymphoblastic Leukemia	560		clinicaltrials.gov
October 28, 2025	NCT07221656	Evaluation of Prolonged Asparaginase Activity Levels After Calaspargase Pegol Administration	Mayo Clinic	Observational	Not yet recruiting	Childhood Acute Lymphoblastic Leukemia, Childhood Lymphoblastic Lymphoma	20	United States	clinicaltrials.gov
October 2, 2025	NCT07203742	The Effect of Mandala on Anxiety and Fear Levels in Children With Leukemia Before Intrathecal Chemotherapy Treatment	Ege University	Not applicable	Recruiting	Acute Lymphoblastic Leukemia, Childhood Acute Leukemia, Acute Myeloblastic Leukaemia	60	Turkey (Türkiye)	clinicaltrials.gov
October 2, 2025	NCT07203352	Efficacy of Targeted Drugs Combined With Chemotherapy in the Treatment of T-ALL	Nanfang Hospital, Southern Medical University	Phase 3	Recruiting	Acute Lymphoblastic Leukemia	154	China	clinicaltrials.gov
September 25, 2025	NCT07192237	Phase 2 Study to Assess the Safety and Efficacy of Subcutaneous Blinatumomab in Patients With Measurable Residual Disease Positive B-cell...	M.D. Anderson Cancer Center	Phase 2	Suspended	Phase 2 Study, Blinatumomab, Acute Lymphoblastic Leukemia	40	United States	clinicaltrials.gov
September 24, 2025	NCT07191119	Transcutaneous Auricular Vagus Nerve Stimulation for Insomnia in Survivors of Childhood Acute Lymphoblastic Leukemia	St. Jude Children's Research Hospital	Not applicable	Recruiting	Survivor of Childhood Cancer, Insomnia, Acute Lymphoblastic Leukemia (ALL)	40	United States	clinicaltrials.gov
September 17, 2025	NCT07178912	Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive...	M.D. Anderson Cancer Center	Phase 2	Not yet recruiting	Phase II Clinical Trial, Blinatumomab, Olverembatinib, Lymphoblastic Leukemia, Philadelphia Chromosome Positive	60	United States	clinicaltrials.gov

Sponsors posting most

Sponsor	New trials	Latest
St. Jude Children's Research Hospital	9	October 20, 2026
Institute of Hematology & Blood Diseases Hospital, China	9	August 25, 2026
M.D. Anderson Cancer Center	6	October 5, 2026
First Affiliated Hospital of Zhejiang University	6	June 4, 2025
The First Affiliated Hospital of Soochow University	4	May 8, 2026
National Cancer Institute (NCI)	4	May 7, 2026
City of Hope Medical Center	4	June 13, 2025
The Children's Hospital of Zhejiang University School of Medicine	3	September 10, 2026
Novartis Pharmaceuticals	3	June 12, 2026
Memorial Sloan Kettering Cancer Center	3	May 5, 2026
Assiut University	3	April 3, 2026
Shanxi Bethune Hospital	3	January 28, 2026
Ruijin Hospital	3	December 24, 2025
Hospital Universitario Dr. Jose E. Gonzalez	2	October 22, 2026
Wake Forest University Health Sciences	2	September 9, 2026
Ossium Health, Inc.	2	July 17, 2026
Zhujiang Hospital	2	July 10, 2026
Resonance, Inc.	2	June 8, 2026
Gruppo Italiano Malattie EMatologiche dell'Adulto	2	June 3, 2026
Dana-Farber Cancer Institute	2	April 8, 2026

By phase

Phase	New trials	Latest
Not applicable	60	November 5, 2026
Observational	34	October 20, 2026
Phase 2	30	September 14, 2026
Phase 1	29	November 6, 2026
Phase 1/2	14	October 22, 2026
Phase 2/3	8	January 26, 2026
Early phase 1	5	July 10, 2026
Phase 4	5	January 6, 2026
Phase 3	3	October 31, 2025

By country

Country	New trials	Latest
United States	61	October 23, 2026
China	44	November 5, 2026
France	7	July 6, 2026
Italy	7	June 12, 2026
Spain	7	June 12, 2026
Egypt	7	June 8, 2026
Australia	6	June 12, 2026
Canada	6	June 12, 2026
Turkey (Türkiye)	5	October 20, 2026
United Kingdom	5	June 12, 2026
Hong Kong	5	September 3, 2025
Denmark	4	August 21, 2026
Germany	4	July 15, 2026
Russia	4	January 26, 2026
Mexico	3	October 22, 2026
South Korea	3	February 4, 2026
Taiwan	3	February 4, 2026
Pakistan	2	July 10, 2026
Israel	2	June 12, 2026
Netherlands	2	June 12, 2026
Poland	2	June 12, 2026
Armenia	2	June 8, 2026
El Salvador	2	June 8, 2026
Guatemala	2	June 8, 2026
Honduras	2	June 8, 2026

Where the register publishes

U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Condition groups are the MeSH terms ClinicalTrials.gov assigns to each study's conditions; a study with several is in several groups. Sponsor class is the register's class of the lead sponsor. The central contact is in the full list only as the record prints it. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.